GAS5 and renal cell carcinoma: Liu et al. found that lncRNA GAS5 was decreased in sorafenib‐resistant renal cell carcinoma cells, but overexpression of GAS5 sensitized the cells to the drug by sequestering miR‐21 and upregulating SOX5.102